Developer docs
API playgroundTry for free, no card

Search company profiles

LifeSci Partners

Full company profile

uuid000agu6

Namestring
LifeSci Partners
Legal namestring
LifeSci Partners
Company typeenum
Private
Founded yearstring
-
Descriptiontext

LifeSci Partners is a privately held, New York–headquartered life sciences and healthcare consultancy that operates an integrated platform of nine complementary sub-businesses serving biotech, pharmaceutical, and medical technology clients across their full corporate lifecycle, from inception through maturity. The platform spans investor relations (LifeSci Advisors), regulated investment banking services including corporate finance, private banking, SPAC advisory, and M&A advisory (LifeSci Capital, a FINRA/SIPC member), integrated healthcare communications (LifeSci Communications), global strategy consulting and transaction advisory (LifeSci Consulting), biopharma-focused event coordination, production, and marketing (LifeSci Events), C-suite, board, and VP-level executive search plus interim leadership placements and buy-side Partner/Principal appointments (LifeSci Search), and friendly growth capital for transformational healthcare businesses (LifeSci Venture). The firm also runs the annual LifeSci CAE conference franchise and uses a dedicated events platform to host KOL events, R&D webinars, and Capital Markets Days on behalf of public and private life sciences issuers.

The company's business model is a relationship-driven professional services and capital markets platform: revenue is generated from advisory fees (IR retainers, consulting and transaction advisory mandates), regulated investment banking fees on capital markets and M&A engagements, communications agency project fees, event production and sponsorship revenue, executive search contingency or retainer fees, and capital deployment economics via LifeSci Venture. Go-to-market is direct, enterprise-focused, and centered on C-suite and senior leadership relationships within life sciences issuers, complemented by an event-based top-of-funnel channel through LifeSci Events and the annual CAE conference. The firm explicitly markets a global presence leveraging local relationships across multiple territories, though its only disclosed office is the 1700 Broadway, 40th Floor headquarters in New York. There is no disclosed pricing model in the input data, and the customer base, while identifiable through individual events (e.g., Arrowhead Pharmaceuticals, Elicio Therapeutics, Hansa Biopharma, Transgene), is not enumerated as a customer roster.

Operationally, the firm sits in a specialized niche of life sciences advisory where domain expertise and regulatory licensing (notably the FINRA/SIPC registration of LifeSci Capital) function as structural entry barriers. The absence of disclosed headcount trends, financial figures, M&A activity, or funding rounds in the input data limits any quantitative revenue or growth trajectory analysis; however, the live website, active 2026 events calendar, and continued marketing of the nine-vertical platform all indicate an operating, ongoing business.

Short descriptiontext

LifeSci Partners is a privately held, New York–headquartered life sciences consultancy operating an integrated platform of nine businesses delivering investor relations, regulated investment banking, healthcare communications, strategy consulting, events, executive search, and venture capital services to biotech, pharmaceutical, and medical technology clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences consulting, investor relations services, healthcare communications, biotech investment banking, pharmaceutical executive search
Industry3 codes
1Healthcare & Life Sciences PR
CodeBPAFADAJPrimaryYes
2Life Sciences & Biotechnology Congresses
CodeTHAHAJABPrimaryNo
3Healthcare & Life Sciences Leadership Search
CodeBPACAAAEPrimaryNo
NAICS code3 codes
  • Management Consulting Services54161
  • Marketing Consulting Services541613
  • Portfolio Management and Investment Advice523940
SIC code3 codes
  • Services-Management Consulting Services8742
  • Security Brokers, Dealers & Flotation Companies6211
  • Investment Advice6282
Product category
Life Sciences Advisory Services
Social media profiles1 record
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1LifeSci Advisors
Description

A unique investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach.

lifescipartners.com
+6 more records
Core offering1 text field

LifeSci Partners operates an integrated platform of nine distinct life sciences businesses providing investor relations, investment banking, healthcare communications, strategy consulting, biopharma event coordination, executive search, and venture capital services. The platform serves life science companies across their entire lifecycle, from inception to maturity, addressing the diverse skill sets and resources required to move from scientific conception to profitable exit.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

LifeSci Partners operates as a platform ecosystem comprising 9 distinct businesses: LifeSci Advisors (investor relations), LifeSci Capital (investment banking), LifeSci Communications (healthcare communications), LifeSci Consulting (strategy consulting), LifeSci Events (event coordination), LifeSci Search (executive search), and LifeSci Venture (healthcare capital), all integrated under the LifeSci Platform. The platform also hosts LifeSci CAE, an annual conference. These businesses collectively provide life science companies with resources and expertise across the full lifecycle from inception to maturity.

Product and service9 records
1LifeSci Platform
CategoryIntegrated Advisory Platform
Description

Unified ecosystem of nine distinct life sciences businesses integrated under one roof, providing comprehensive solutions for life science companies at all stages of their lifecycle.

2LifeSci Advisors
CategoryInvestor Relations
Description

Investor relations consultancy providing companies in the life sciences with comprehensive solutions for investor communications and outreach.

3LifeSci Capital
CategoryInvestment Banking
Description

Research-driven investment bank with a sole focus on the life sciences, offering corporate finance, private banking, SPAC and M&A advisory services (member FINRA/SIPC).

4LifeSci Communications
CategoryHealthcare Communications
Description

Integrated healthcare communications agency focused on transforming complex science into compelling stories that demand and receive attention.

5LifeSci Consulting
CategoryManagement Consulting
Description

Global strategy consulting and transaction advisory firm optimizing value for client organizations, products, and portfolios.

6LifeSci Events
CategoryEvent Management
Description

Biopharma-focused events agency specializing in event coordination, production, and marketing, including R&D webinars, KOL events, and Capital Markets Days.

7LifeSci Search
CategoryExecutive Search
Description

Executive search division operating within biotechnology, pharmaceutical and medical technology sectors, providing permanent and interim leadership solutions at C-Suite, Board of Directors, and VP levels, and supporting buy-side firms with Partner and Principal appointments.

8LifeSci Venture
CategoryVenture Capital
Description

Provides friendly capital to accelerate transformational businesses across the healthcare space.

9LifeSci CAE 2026
CategoryConference and Events
Description

Annual LifeSci Partners conference event for the life sciences community.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Lazar Partners is a long-standing life sciences public relations and investor relations firm serving biotech and pharma. It competes head-to-head with LifeSci Advisors and LifeSci Communications on healthcare IR and PR mandates.

TypeDirect peer
Description

Zyme Communications is a life sciences PR and communications agency with a similar biotech, pharma, and medtech client base. It is directly comparable to LifeSci Communications on healthcare storytelling, medical communications, and media relations.

TypeBroad incumbent
Description

Inizio Evoke is a large global commercial and communications agency with deep healthcare and life sciences practices. It is a broader incumbent that competes with LifeSci Communications and LifeSci Consulting across integrated healthcare marketing and advisory, but at meaningfully greater scale and breadth.

4Canale Communications
TypeDirect peer
Description

Canale Communications is a life sciences PR and communications agency specializing in biotech, pharma, and medtech. It is directly comparable to LifeSci Communications and the broader LifeSci platform's communications emphasis for scientific storytelling in the healthcare sector.

TypeDirect peer
Description

Solebury Trout is a life sciences-focused investor relations and capital markets advisory firm. It maps directly onto LifeSci Advisors and LifeSci Capital as a peer in biotech IR, equity capital markets advisory, and shareholder communications.

TypeDirect peer
Description

Burns McClellan is a healthcare/life sciences communications and IR agency serving biotech, pharmaceutical, and medical device companies. It is a direct competitor to LifeSci Advisors and LifeSci Communications for healthcare IR and PR mandates.

TypeDirect peer
Description

Argot Partners is a healthcare-focused investor relations and corporate communications firm serving biotech, pharma, and medtech. It directly mirrors LifeSci Advisors and LifeSci Communications for scientific IR and corporate communications.

TypeDirect peer
Description

ICR is the closest direct peer, running healthcare-specialized investor relations, strategic communications, and capital markets advisory for life sciences companies. Like LifeSci Partners, it offers a multi-discipline services platform targeting biotech, pharma, and medtech issuers across the IR-to-IPO continuum.

TypeBroad incumbent
Description

Syneos Health is a large clinical and commercial biopharma services platform with a healthcare communications arm. It is a broad incumbent competing with multiple LifeSci sub-brands (especially Communications and Consulting) at much larger scale, with deeper biopharma services breadth.

TypeDirect peer
Description

Rx Communications is a healthcare and life sciences public relations firm serving biotech and pharmaceutical clients. It maps directly onto LifeSci Communications as a direct specialist competitor in the healthcare communications space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LifeSci Partners

Life Sciences Advisory Serviceslifescipartners.com

LifeSci Partners is a privately held, New York–headquartered life sciences consultancy operating an integrated platform of nine businesses delivering investor relations, regulated investment banking, healthcare communications, strategy consulting, events, executive search, and venture capital services to biotech, pharmaceutical, and medical technology clients.

What LifeSci Partners does

LifeSci Partners is a privately held, New York–headquartered life sciences and healthcare consultancy that operates an integrated platform of nine complementary sub-businesses serving biotech, pharmaceutical, and medical technology clients across their full corporate lifecycle, from inception through maturity. The platform spans investor relations (LifeSci Advisors), regulated investment banking services including corporate finance, private banking, SPAC advisory, and M&A advisory (LifeSci Capital, a FINRA/SIPC member), integrated healthcare communications (LifeSci Communications), global strategy consulting and transaction advisory (LifeSci Consulting), biopharma-focused event coordination, production, and marketing (LifeSci Events), C-suite, board, and VP-level executive search plus interim leadership placements and buy-side Partner/Principal appointments (LifeSci Search), and friendly growth capital for transformational healthcare businesses (LifeSci Venture). The firm also runs the annual LifeSci CAE conference franchise and uses a dedicated events platform to host KOL events, R&D webinars, and Capital Markets Days on behalf of public and private life sciences issuers.

The company's business model is a relationship-driven professional services and capital markets platform: revenue is generated from advisory fees (IR retainers, consulting and transaction advisory mandates), regulated investment banking fees on capital markets and M&A engagements, communications agency project fees, event production and sponsorship revenue, executive search contingency or retainer fees, and capital deployment economics via LifeSci Venture. Go-to-market is direct, enterprise-focused, and centered on C-suite and senior leadership relationships within life sciences issuers, complemented by an event-based top-of-funnel channel through LifeSci Events and the annual CAE conference. The firm explicitly markets a global presence leveraging local relationships across multiple territories, though its only disclosed office is the 1700 Broadway, 40th Floor headquarters in New York. There is no disclosed pricing model in the input data, and the customer base, while identifiable through individual events (e.g., Arrowhead Pharmaceuticals, Elicio Therapeutics, Hansa Biopharma, Transgene), is not enumerated as a customer roster.

Operationally, the firm sits in a specialized niche of life sciences advisory where domain expertise and regulatory licensing (notably the FINRA/SIPC registration of LifeSci Capital) function as structural entry barriers. The absence of disclosed headcount trends, financial figures, M&A activity, or funding rounds in the input data limits any quantitative revenue or growth trajectory analysis; however, the live website, active 2026 events calendar, and continued marketing of the nine-vertical platform all indicate an operating, ongoing business.

LifeSci Partners firmographics

Firmographics
Name
LifeSci Partners
Legal name
LifeSci Partners
Website
https://lifescipartners.com
Company type
Private
Operating status
Operating
Headcount range
51–100 employees
Short description
LifeSci Partners is a privately held, New York–headquartered life sciences consultancy operating an integrated platform of nine businesses delivering investor relations, regulated investment banking, healthcare communications, strategy consulting, events, executive search, and venture capital services to biotech, pharmaceutical, and medical technology clients.
Ownership category
akta.pro rank

LifeSci Partners industry classification

Industry
Product category
Life Sciences Advisory Services
NAICS
Management Consulting Services (54161), Marketing Consulting Services (541613), Portfolio Management and Investment Advice (523940)
SIC
Services-Management Consulting Services (8742), Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)
akta.pro primary industry
Healthcare & Life Sciences PR (BPAFADAJ)
akta.pro secondary industries
Life Sciences & Biotechnology Congresses (THAHAJAB), Healthcare & Life Sciences Leadership Search (BPACAAAE)

Keywords

  • Life sciences consulting
  • Investor relations services
  • Healthcare communications
  • Biotech investment banking
  • Pharmaceutical executive search

Where LifeSci Partners is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

LifeSci Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels1 record

LifeSci Partners product offering

Product offering

Core offering

LifeSci Partners operates an integrated platform of nine distinct life sciences businesses providing investor relations, investment banking, healthcare communications, strategy consulting, biopharma event coordination, executive search, and venture capital services. The platform serves life science companies across their entire lifecycle, from inception to maturity, addressing the diverse skill sets and resources required to move from scientific conception to profitable exit.

Product overview

LifeSci Partners operates as a platform ecosystem comprising 9 distinct businesses: LifeSci Advisors (investor relations), LifeSci Capital (investment banking), LifeSci Communications (healthcare communications), LifeSci Consulting (strategy consulting), LifeSci Events (event coordination), LifeSci Search (executive search), and LifeSci Venture (healthcare capital), all integrated under the LifeSci Platform. The platform also hosts LifeSci CAE, an annual conference. These businesses collectively provide life science companies with resources and expertise across the full lifecycle from inception to maturity.

Differentiator

Problem solved

Functional benefit

Brands

  • LifeSci Advisors: A unique investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach.
  • LifeSci Capital
  • LifeSci Communications
  • LifeSci Consulting
  • LifeSci Events
  • LifeSci Search
  • LifeSci Venture

Products and services

  • LifeSci Platform Unified ecosystem of nine distinct life sciences businesses integrated under one roof, providing comprehensive solutions for life science companies at all stages of their lifecycle.
  • LifeSci Advisors Investor relations consultancy providing companies in the life sciences with comprehensive solutions for investor communications and outreach.
  • LifeSci Capital Research-driven investment bank with a sole focus on the life sciences, offering corporate finance, private banking, SPAC and M&A advisory services (member FINRA/SIPC).
  • LifeSci Communications Integrated healthcare communications agency focused on transforming complex science into compelling stories that demand and receive attention.
  • LifeSci Consulting Global strategy consulting and transaction advisory firm optimizing value for client organizations, products, and portfolios.
  • LifeSci Events Biopharma-focused events agency specializing in event coordination, production, and marketing, including R&D webinars, KOL events, and Capital Markets Days.
  • LifeSci Search Executive search division operating within biotechnology, pharmaceutical and medical technology sectors, providing permanent and interim leadership solutions at C-Suite, Board of Directors, and VP levels, and supporting buy-side firms with Partner and Principal appointments.
  • LifeSci Venture Provides friendly capital to accelerate transformational businesses across the healthcare space.
  • LifeSci CAE 2026 Annual LifeSci Partners conference event for the life sciences community.

Companies that use LifeSci Partners

Customer profile

Segments1 record

Ideal customer profiles2 records

LifeSci Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

LifeSci Partners partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

LifeSci Partners competitors and assessment

Company assessment

Direct peers

  • Lazar Partners (now Lazar/Quinn): Lazar Partners is a long-standing life sciences public relations and investor relations firm serving biotech and pharma. It competes head-to-head with LifeSci Advisors and LifeSci Communications on healthcare IR and PR mandates.
  • Zyme Communications: Zyme Communications is a life sciences PR and communications agency with a similar biotech, pharma, and medtech client base. It is directly comparable to LifeSci Communications on healthcare storytelling, medical communications, and media relations.
  • Canale Communications: Canale Communications is a life sciences PR and communications agency specializing in biotech, pharma, and medtech. It is directly comparable to LifeSci Communications and the broader LifeSci platform's communications emphasis for scientific storytelling in the healthcare sector.
  • Solebury Trout Group: Solebury Trout is a life sciences-focused investor relations and capital markets advisory firm. It maps directly onto LifeSci Advisors and LifeSci Capital as a peer in biotech IR, equity capital markets advisory, and shareholder communications.
  • Burns McClellan: Burns McClellan is a healthcare/life sciences communications and IR agency serving biotech, pharmaceutical, and medical device companies. It is a direct competitor to LifeSci Advisors and LifeSci Communications for healthcare IR and PR mandates.
  • Argot Partners: Argot Partners is a healthcare-focused investor relations and corporate communications firm serving biotech, pharma, and medtech. It directly mirrors LifeSci Advisors and LifeSci Communications for scientific IR and corporate communications.
  • ICR (Westwicke): ICR is the closest direct peer, running healthcare-specialized investor relations, strategic communications, and capital markets advisory for life sciences companies. Like LifeSci Partners, it offers a multi-discipline services platform targeting biotech, pharma, and medtech issuers across the IR-to-IPO continuum.
  • Rx Communications Group: Rx Communications is a healthcare and life sciences public relations firm serving biotech and pharmaceutical clients. It maps directly onto LifeSci Communications as a direct specialist competitor in the healthcare communications space.

Broad incumbents

  • Evoke Group (Inizio Evoke): Inizio Evoke is a large global commercial and communications agency with deep healthcare and life sciences practices. It is a broader incumbent that competes with LifeSci Communications and LifeSci Consulting across integrated healthcare marketing and advisory, but at meaningfully greater scale and breadth.
  • Syneos Health Communications: Syneos Health is a large clinical and commercial biopharma services platform with a healthcare communications arm. It is a broad incumbent competing with multiple LifeSci sub-brands (especially Communications and Consulting) at much larger scale, with deeper biopharma services breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

LifeSci Partners social profiles

Digital presence

LifeSci Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LifeSci Partners leadership team

Management profile

Number of profiles

LifeSci Partners subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

LifeSci Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LifeSci Partners M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeSci Partners

What does LifeSci Partners do?

LifeSci Partners operates an integrated platform of nine distinct life sciences businesses providing investor relations, investment banking, healthcare communications, strategy consulting, biopharma event coordination, executive search, and venture capital services. The platform serves life science companies across their entire lifecycle, from inception to maturity, addressing the diverse skill sets and resources required to move from scientific conception to profitable exit.

Is LifeSci Partners a public or private company?

LifeSci Partners is a private company. It is classified as unknown and is currently operating.

When was LifeSci Partners founded?

LifeSci Partners was founded in -1. It employs 51 to 100 people.

Where is LifeSci Partners based?

LifeSci Partners is headquartered in New York, United States, in the North America region.

Who are LifeSci Partners's main competitors?

Direct peers on record are Lazar Partners (now Lazar/Quinn), Zyme Communications, Canale Communications, Solebury Trout Group, Burns McClellan, Argot Partners, ICR (Westwicke) and Rx Communications Group. Broad incumbents are Evoke Group (Inizio Evoke) and Syneos Health Communications.

Does LifeSci Partners have an API?

No public API is recorded for LifeSci Partners.

What industry is LifeSci Partners in?

LifeSci Partners's product category is Life Sciences Advisory Services. Its primary akta.pro industry code is BPAFADAJ, Healthcare & Life Sciences PR, with a secondary code of THAHAJAB, Life Sciences & Biotechnology Congresses. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireRESTEM to Participate in the 15th LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference in January 2026RESTEM announced its management team will participate in the 15th LifeSci Partners Corporate Access event in San Francisco, January 12-14, 2026. The company, a clinical-stage biotech developing off-the-shelf cell therapies, will offer one-on-one meetings to investors during the event.GlobeNewswireMendus to participate in several investor and industry conferences in JanuaryMendus AB announced its participation in three investor and industry conferences in January 2024, including the J.P. Morgan Healthcare Conference and LifeSci Partners Corporate Access Event in San Francisco, and the Redeye Theme: Fight Cancer event in Stockholm. The company will present its tumor-recurrence immunotherapy pipeline at these events.GlobeNewswireKineta to Participate in the 13th Annual LifeSci Partners Corporate Access EventKineta announced its management will participate in the 13th Annual LifeSci Partners Corporate Access Event on January 8-10, 2024 in San Francisco. The company will host one-on-one meetings and present an update on its VISTA-101 Phase 1/2 clinical trial for KVA12123, a VISTA blocking immunotherapy.GlobeNewswireLumos Pharma to Participate in 12th Annual LifeSci Partners Corporate Access Event January 9-11, 2023Lumos Pharma will host in-person meetings with the investment and biopharmaceutical community at the 12th Annual LifeSci Partners Corporate Access Event in San Francisco on January 10-11, 2023. The company's lead candidate, LUM-201, an oral growth hormone stimulating small molecule, is in Phase 2 trials for Pediatric Growth Hormone Deficiency and has received Orphan Drug Designation in the US and EU.PR NewswireSeelos Therapeutics to Participate in the 12th Annual LifeSci Partners Corporate Access EventSeelos Therapeutics announced it will participate in the 12th Annual LifeSci Partners Corporate Access Event, scheduled to be held in San Francisco, California on January 9-11, 2023. The company's CEO highlighted several clinical programs including registrational studies in acute suicidal ideation and behavior, amyotrophic lateral sclerosis, and spinocerebellar ataxia, as well as preclinical data in Huntington's and Parkinson's diseases. The event will feature more than 200 biotechnology, medical technology, and life sciences companies participating in in-person meetings with senior management teams.GlobeNewswireOptimizeRx to Participate in Upcoming Investor ConferencesOptimizeRx Corp. announced management will participate in three upcoming investor conferences: Piper Sandler, J.P. Morgan, and LifeSci Partners. The events are scheduled for November 29–December 1, 2022, and January 9–12, 2023, with presentation and meeting details provided.GlobeNewswireSofwave Participate in LifeSci Partners HealthTech SymposiumSofwave Medical will participate in a virtual fireside chat at the LifeSci Partners HealthTech Symposium on September 21, 2022, at 11:00 a.m. ET. The event is virtual, with live and archived webcasts available on Sofwave's website. The symposium highlights public/private digital health and medtech companies.GlobeNewswireNanox to Present at Two Upcoming Investor Conferences in September 2022Nanox Imaging will present at two investor conferences in September 2022, with CEO Erez Meltzer and CFO Ran Daniel delivering presentations. The conferences are the LifeSci Partners HealthTech Symposium on September 20-21 and the Ladenburg Thalmann Healthcare Conference on September 29. Both presentations will be available via live webcast.GlobeNewswireLifeSci Partners Launches LifeSci Events, Life Sciences-focused Corporate Event Planning AgencyLifeSci Partners launched LifeSci Events, a corporate event planning agency for life sciences companies. The division offers turnkey services for virtual meetings, conferences, and offsites, leveraging the company's investor relations and KOL relationships. It will be led by Sara Parigian, who has planned over 800 events in seven years.GlobeNewswireVYNE Therapeutics to Present at LifeSci Partners’ Immunology & Inflammation Symposium on May 10thVYNE Therapeutics announced that CEO David Domzalski and CSO Dr. Iain Stuart will present at LifeSci Partners' virtual Immunology and Inflammation Symposium on May 10-11, 2022. The webcast replay will be available on the company's website for 90 days.